Diagnosis and antibiotic treatment of community-acquired pneumonia.
AUTOR(ES)
Rodnick, J. E.
RESUMO
Only a few pathogens cause most community-acquired pneumonias. In outpatients, treatment is empiric, based on the results of chest films, leukocyte counts, and Gram's stains (if available). Antibiotics must always cover pneumococci and should cover Mycoplasma pneumoniae in young adults and during epidemic periods. A follow-up chest film in smokers and those older than 40 years is strongly recommended. In inpatients, the evaluation and treatment are tailored to individual cases. A search for a wider range of causes, using invasive tests if necessary, is undertaken, and all likely pathogens should be covered with the initial antibiotic therapy.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1002786Documentos Relacionados
- Community-acquired Chlamydia pneumoniae pneumonia.
- Comparison of cefdinir and cefaclor in treatment of community-acquired pneumonia.
- Comparison of cefadroxil and cephalexin in the treatment of community-acquired pneumonia.
- Sputum gram stain assessment in community-acquired bacteremic pneumonia.
- Ampicillin versus cefamandole as initial therapy for community-acquired pneumonia.